Company Profile
Cellcentric Limited
04948632•Private Limited With Share Capital
Get Full Access
30/10/2003
22 years
7
19
72110
moderate risk
Company Overview
Registration, classification & business activity
Cellcentric Limited (04948632) is a private limited with share capital incorporated on 30/10/2003 (22 years old) and registered in cambridge, CB101XL. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and cbp. it is formulated as a capsule taken orally.p300/cbp are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certai...
Financial Overview
£41.04M
£3.33M
£37.72M
£38.42M
Key Metrics
19
Employees
7
Directors
5
Shareholders
7
Patents
Board of Directors
Charges
6
Registered
0
Outstanding
0
Part Satisfied
6
Satisfied
Innovate Grants
This company received a grant of £126000.0 for A New Application For A Novel Drug Candidate - In Lung Cancer. The project started on 01/01/2017 and ended on 31/12/2017.
Import / Export
Risk Assessment
moderate risk
International Score
Future Factor
fair
Performance Rating